Related Experiment Video
Updated: Mar 8, 2026

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
TRIP13 is expressed in colorectal cancer and promotes cancer cell invasion
Kenji Kurita1, Masao Maeda2, Mohammed A Mansour2
1Department of Surgical Oncology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Abstract:
Thyroid hormone receptor interactor 13 (TRIP13) is a member of the ATPases associated with various cellular activities family of proteins and is highly conserved in a wide range of species. Recent studies have demonstrated that TRIP13 is critical for the inactivation of the spindle assembly checkpoint and is associated with the progression of certain cancers. In the present study, the role of TRIP13 in colorectal cancer (CRC) was examined. Reverse transcription-quantitative polymerase chain reaction analysis revealed that TRIP13 messenger RNA was highly expressed in multiple CRC tissues. The depletion of TRIP13 in CRC cells suppressed cell proliferation, migration and invasion. To determine whether the catalytic activity of TRIP13 was critical for cancer progression, an inactive mutant of TRIP13 was expressed in CRC cells. The invasion of cancer cells that expressed the mutant TRIP13 was significantly reduced compared with that of the wild type TRIP13-expressing cancer cells. These results indicate that TRIP13 could be a potential target for CRC treatment.
Insights
Thyroid hormone receptor interactor 13 (TRIP13) is crucial in colorectal cancer (CRC) progression. Inhibiting TRIP13 in CRC cells reduced proliferation and invasion, suggesting TRIP13 as a potential therapeutic target for CRC.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Thyroid hormone receptor interactor 13 (TRIP13) is an evolutionarily conserved protein involved in the ATPases associated with various cellular activities (AAA) family.
- TRIP13 plays a critical role in the spindle assembly checkpoint inactivation and is implicated in various cancer progressions.
Purpose of the Study:
- To investigate the role of TRIP13 in colorectal cancer (CRC).
- To determine if TRIP13's catalytic activity is essential for cancer progression.
Main Methods:
- Quantitative reverse transcription-polymerase chain reaction (RT-qPCR) to assess TRIP13 mRNA expression in CRC tissues.
- Depletion of TRIP13 in CRC cell lines to evaluate its effect on proliferation, migration, and invasion.
- Expression of a catalytically inactive TRIP13 mutant in CRC cells to assess the role of its enzymatic activity.
Main Results:
- TRIP13 mRNA was significantly overexpressed in multiple CRC tissues.
- Depletion of TRIP13 suppressed CRC cell proliferation, migration, and invasion.
- Expression of an inactive TRIP13 mutant markedly reduced cancer cell invasion compared to wild-type TRIP13.
Conclusions:
- TRIP13 is highly expressed in colorectal cancer and promotes tumor progression.
- TRIP13's catalytic activity is essential for its role in CRC invasion.
- TRIP13 represents a potential therapeutic target for colorectal cancer treatment.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

